MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare Cosential vs Microsoft Dynamics GP

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better Cosential or Microsoft Dynamics GP? If you wish to have a easy way to find out which CRM Software product is better, our proprietary system gives Cosential a score of 7.0 and Microsoft Dynamics GP a score of 8.9 for general quality and performance. In addition, Cosential is rated at 100%, while Microsoft Dynamics GP is rated 97% for their user satisfaction level.

You can also review their product details, such as features, tools, options, plans, costs, and others. Find out if the application allows you to customize a few of its funnels to make sure the software fits your own business processes.

At this time, the most significant products in our CRM Software category are: Salesforce CRM, HubSpot Smart CRM, Freshsales.

The solutions compared on this page are only a small sample of our entire CRM Software category and you should keep in mind that there could be better options out there. If you want to guarantee you make the wisest choice for your team we strongly encourage you to analyze more services first. It may also be a good idea to consult our top 10 CRM Software ranking to see which services are currently the best ones and dominate the market.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.